Whitehawk Therapeutics (WHWK) Other Operating Expenses (2010 - 2025)
Whitehawk Therapeutics (WHWK) reported Other Operating Expenses of -$177000.0 for Q3 2025, down 100.2% on a QoQ basis from $87.4 million in Q1 2025.
Whitehawk Therapeutics (WHWK) has 9 years of Other Operating Expenses data on file, last reported at -$177000.0 in Q3 2025.
- Quarterly Other Operating Expenses changed N/A year-over-year to -$177000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$177000.0 (down 100.2% YoY) and the FY2025 annual result came in at $87.3 million, changed N/A from the prior year.
- Other Operating Expenses declined to -$177000.0 in Q3 2025 per WHWK's latest filing, from $87.4 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $87.4 million in Q1 2025 and bottomed at -$177000.0 in Q3 2025.
- The 4-year median for Other Operating Expenses is $656000.0 (2023), against an average of $15.4 million.
- The widest annual swing landed in 2022, when Other Operating Expenses sank 99.2%; it then surged 317.57% in 2023.
- Tracing WHWK's Other Operating Expenses over 4 years: stood at $74.2 million in 2021, then sank by 99.7% to $222000.0 in 2022, then jumped by 317.57% to $927000.0 in 2023, then tumbled by 119.09% to -$177000.0 in 2025.
- Per Business Quant, the three latest WHWK Other Operating Expenses figures stand at -$177000.0 (Q3 2025), $87.4 million (Q1 2025), and $927000.0 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -177,000.00 |
| Mar 31, 2025 | 87.44 Mn |
| Dec 31, 2023 | 927,000.00 |
| Sep 30, 2023 | 697,000.00 |
| Jun 30, 2023 | 656,000.00 |
| Mar 31, 2023 | 529,000.00 |
| Dec 31, 2022 | 222,000.00 |
| Sep 30, 2022 | 593,000.00 |
| Jun 30, 2022 | 4.07 Mn |
| Mar 31, 2022 | 179,000.00 |
| Sep 30, 2021 | 74.16 Mn |
| Dec 31, 2019 | 987,210.00 |
| Sep 30, 2019 | -38,810.00 |
| Jun 30, 2019 | 915,094.00 |
| Mar 31, 2013 | -4,806.00 |
| Dec 31, 2012 | -8,376.00 |
| Sep 30, 2012 | -4,753.00 |
| Jun 30, 2012 | -5,031.00 |
| Mar 31, 2012 | -4,231.00 |
| Dec 31, 2011 | -8,026.00 |
| Sep 30, 2011 | -5,430.00 |
| Jun 30, 2011 | -5,862.00 |
| Mar 31, 2011 | -4,266.00 |
| Dec 31, 2010 | -7,214.00 |
| Sep 30, 2010 | -4,238.00 |